DE69917477D1 - Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen - Google Patents

Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen

Info

Publication number
DE69917477D1
DE69917477D1 DE69917477T DE69917477T DE69917477D1 DE 69917477 D1 DE69917477 D1 DE 69917477D1 DE 69917477 T DE69917477 T DE 69917477T DE 69917477 T DE69917477 T DE 69917477T DE 69917477 D1 DE69917477 D1 DE 69917477D1
Authority
DE
Germany
Prior art keywords
estrogenens
progestines
administration
drug disposal
disposal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69917477T
Other languages
English (en)
Other versions
DE69917477T2 (de
Inventor
Tommi Markkula
Juha Ala-Sorvari
Harri Jukarainen
Matti Lehtinen
Jarkko Ruohonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Oy
Original Assignee
Schering Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Oy filed Critical Schering Oy
Application granted granted Critical
Publication of DE69917477D1 publication Critical patent/DE69917477D1/de
Publication of DE69917477T2 publication Critical patent/DE69917477T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Nanotechnology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
DE69917477T 1998-11-12 1999-10-26 Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen Expired - Lifetime DE69917477T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US190606 1998-11-12
US09/190,606 US6063395A (en) 1998-11-12 1998-11-12 Drug delivery device especially for the delivery of progestins and estrogens
PCT/FI1999/000887 WO2000028968A1 (en) 1998-11-12 1999-10-26 Drug delivery device, especially for the delivery of progestins and estrogens

Publications (2)

Publication Number Publication Date
DE69917477D1 true DE69917477D1 (de) 2004-06-24
DE69917477T2 DE69917477T2 (de) 2005-06-02

Family

ID=22702031

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69917477T Expired - Lifetime DE69917477T2 (de) 1998-11-12 1999-10-26 Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen

Country Status (30)

Country Link
US (1) US6063395A (de)
EP (1) EP1128811B1 (de)
JP (1) JP2002529493A (de)
KR (1) KR100621426B1 (de)
CN (1) CN1168439C (de)
AR (1) AR021152A1 (de)
AT (1) ATE267004T1 (de)
AU (1) AU760302B2 (de)
BG (1) BG65042B1 (de)
BR (1) BR9915326B1 (de)
CA (1) CA2351068C (de)
CO (1) CO5271704A1 (de)
CZ (1) CZ301609B6 (de)
DE (1) DE69917477T2 (de)
DK (1) DK1128811T3 (de)
EE (1) EE05506B1 (de)
ES (1) ES2221454T3 (de)
HK (1) HK1041814B (de)
HU (1) HU226113B1 (de)
ID (1) ID29190A (de)
IL (2) IL142523A0 (de)
NO (1) NO332168B1 (de)
NZ (1) NZ511216A (de)
PE (1) PE20001041A1 (de)
PL (1) PL194876B1 (de)
PT (1) PT1128811E (de)
RU (1) RU2226387C2 (de)
SK (1) SK286730B6 (de)
WO (1) WO2000028968A1 (de)
ZA (1) ZA200103298B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US20060110424A1 (en) * 2000-03-24 2006-05-25 Lyles Mark B Ceramic and metal compositions
EP1272440A2 (de) * 2000-03-24 2003-01-08 Mark B. Lyles Poröse materialien hoher dichte
US6299894B1 (en) 2000-05-10 2001-10-09 Leiras Oy Drug delivery device, especially for the delivery of gestodene
AU2001258442A1 (en) * 2000-05-10 2001-11-20 Leiras Oy Drug delivery device, especially for the delivery of levonorgestrel
ATE311201T1 (de) * 2000-08-23 2005-12-15 Akzo Nobel Nv Testosteron-ester formulierung zur anwendung am menschen
DE20015416U1 (de) 2000-09-06 2000-12-14 Bachmann, Karl-Heinz, 78667 Villingendorf Intrauterine Vorrichtung mit einem oder mehreren Pharmakadepots und integrierten Stellmitteln zur Variation der Abgabedosis
AU2002210580A1 (en) * 2000-10-20 2002-04-29 Leiras Oy Drug delivery system
WO2003017971A1 (en) * 2001-08-31 2003-03-06 Schering Oy Drug delivery system
ES2388731T5 (es) * 2002-03-27 2018-01-19 Warner Chilcott (Ireland) Limited Dispositivos de administración de fármacos mediante una matriz intravaginal
EP1553899A4 (de) * 2002-10-22 2006-10-25 Verfahren und system für die intravesikuläre abgabe von therapeutischen mitteln
EP1438942A1 (de) * 2003-01-17 2004-07-21 Schering Oy Medikamentenabgabevorrichtung für das Mittelohr und Nase
CA2525792C (en) 2003-05-15 2015-10-13 Biomerix Corporation Reticulated elastomeric matrices, their manufacture and use in implantable devices
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
JP5137841B2 (ja) * 2005-10-13 2013-02-06 シンセス ゲーエムベーハー 薬物含浸容器
WO2009029958A2 (en) * 2007-08-30 2009-03-05 Sunstorm Research Corporation Implantable delivery device
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
ATE508734T1 (de) * 2007-11-22 2011-05-15 Bayer Oy System zur vaginalen freisetzung
EP2222281B1 (de) 2007-12-20 2018-12-05 Evonik Corporation Verfahren zur herstellung von mikropartikeln mit geringer restlösemittelmenge
DK2249757T3 (en) 2008-02-04 2017-10-16 Ferring Bv Monolithic vaginal rings comprising progesterone and methods of preparation and use thereof.
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
EP2953558B1 (de) 2013-02-06 2019-08-28 Sillender, Mark Embryonentransferkatheter
AU2014214537B2 (en) 2013-02-06 2019-01-03 Mark SILLENDER Therapeutic substance transfer catheter and method
US20160144067A1 (en) 2013-06-21 2016-05-26 DePuy Synthes Products, Inc. Films and methods of manufacture
EP3294300A1 (de) * 2015-05-13 2018-03-21 Bayer Oy Vorrichtung zur freisetzung eines langwirkenden arzneimittels und dessen verwendung zur verhütung
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant
JOP20200067A1 (ar) * 2017-09-27 2020-04-27 Bayer Oy طريقة لتعديل اطلاق عامل فعال علاجياً من مادة أساس لدنة
US11571328B2 (en) 2018-04-09 2023-02-07 Medicines360 IUD insertion devices
US20200261258A1 (en) 2019-02-19 2020-08-20 Medicines360 Devices, systems, methods and kits for insertion and removal of iuds
US11938140B2 (en) 2022-05-26 2024-03-26 Insigna Inc. Non-surgical prevention of boar taint and aggressive behavior
WO2023230619A1 (en) * 2022-05-26 2023-11-30 Insigna Inc. Prevention of estrus in sow and ruminants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
JPH0778017B2 (ja) * 1985-12-28 1995-08-23 住友製薬株式会社 パルス的かつ持続放出性製剤
IT8702928A0 (it) * 1987-07-22 1987-07-22 Alga Di Giudici Angelamaria & Friggitrice con cestello rotante secondo un asse orizzontale.
ATE86484T1 (de) * 1987-08-08 1993-03-15 Akzo Nv Kontrazeptives implantat.
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
JPH07216233A (ja) * 1992-09-21 1995-08-15 Toray Dow Corning Silicone Co Ltd フルオロシリコーンゴム組成物
US6117442A (en) * 1998-11-12 2000-09-12 Leiras Oy Drug delivery device, especially for the delivery of androgens

Also Published As

Publication number Publication date
EP1128811B1 (de) 2004-05-19
AU1048800A (en) 2000-06-05
CN1168439C (zh) 2004-09-29
ID29190A (id) 2001-08-09
DE69917477T2 (de) 2005-06-02
HK1041814A1 (en) 2002-07-26
CZ20011569A3 (cs) 2001-10-17
HU226113B1 (en) 2008-04-28
CA2351068C (en) 2008-09-02
RU2226387C2 (ru) 2004-04-10
SK5132001A3 (en) 2001-11-06
US6063395A (en) 2000-05-16
AR021152A1 (es) 2002-06-12
BR9915326A (pt) 2001-10-09
ES2221454T3 (es) 2004-12-16
PL194876B1 (pl) 2007-07-31
CN1326337A (zh) 2001-12-12
IL142523A0 (en) 2002-03-10
IL142523A (en) 2006-06-11
BR9915326B1 (pt) 2013-10-22
ATE267004T1 (de) 2004-06-15
NZ511216A (en) 2002-09-27
CA2351068A1 (en) 2000-05-25
NO332168B1 (no) 2012-07-09
KR20010075700A (ko) 2001-08-09
PT1128811E (pt) 2004-09-30
NO20012047D0 (no) 2001-04-26
CO5271704A1 (es) 2003-04-30
ZA200103298B (en) 2001-10-25
HUP0104037A3 (en) 2003-04-28
SK286730B6 (sk) 2009-04-06
WO2000028968A1 (en) 2000-05-25
JP2002529493A (ja) 2002-09-10
KR100621426B1 (ko) 2006-09-13
BG65042B1 (bg) 2007-01-31
BG105501A (en) 2001-12-29
HUP0104037A2 (hu) 2002-04-29
NO20012047L (no) 2001-06-28
CZ301609B6 (cs) 2010-04-28
PL348113A1 (en) 2002-05-06
AU760302B2 (en) 2003-05-08
PE20001041A1 (es) 2000-10-14
EE200100256A (et) 2002-12-16
HK1041814B (zh) 2005-04-29
DK1128811T3 (da) 2004-09-27
EE05506B1 (et) 2012-02-15
EP1128811A1 (de) 2001-09-05

Similar Documents

Publication Publication Date Title
DE69917477D1 (de) Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen
DE69633294D1 (de) Gerät zur infusion und aspiration in, bzw. aus knochen
DE69934773D1 (de) Vorrichtung zur Verabreichung von Medikamenten
DE69720939D1 (de) Vorrichtung zur Abgabe von festen Arzneimitteln
DE69909281D1 (de) Vorrichtung zur präsentation und abgabe von mehreren produkten
DE69907885D1 (de) Spritze und Spritzenkolben
BR9703624A (pt) Combinação formulação farmacêutica processo para o tratamento de depressão em um animal uso de mirtazapina uso de um ou mais srri's e embalagem
DE69911125D1 (de) Vorrichtung zur Verabreichung von Narkosemitteln
DE59811404D1 (de) Medizinisches Gerät, insbesondere zur Senkung des Augeninnendrucks
DE69838218D1 (de) Anatomisch geformte vorrichtung zur gefässokklusion
BR9713237B1 (pt) comprimido de liberaÇço controlada de cloridrato de alfuzosina e composiÇço farmacÊutica compreendendo o mesmo.
DE69827463D1 (de) Vorrichtung zur Vergrösserung von gewebe
NL300258I2 (nl) Farmaceutische samenstelling voor toepassing in debehandeling van.
DE69728357D1 (de) Spritzenhalterung und eine die Halterung aufweisende Injektionsvorrichtung
DE69730882D1 (de) Vorrichtung zur Spritzenanfertigung
CY2009015I1 (el) Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο
DE59813877D1 (de) Vorrichtung zur Regeneration vom menschlichen und tierischen Knochen, insbesondere im Zahnkieferbereich
DE59610469D1 (de) Vorrichtung zur Verabreichung von Substanzen, insbesondere Inhalationspräparate
DE69917825D1 (de) Vorrichtung zur Abgabe von Arzneimitteln
DE60019216D1 (de) Vorrichtung zur Zeitstempelung vom Mappentyp und verteiltes Zeitstempelungssystem
DE69808205D1 (de) Vorrichtung zum Befüllen und zum Verabreichen von Spritzen
DE60131760D1 (de) Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform
DE60038478D1 (de) Vorrichtung zur Injektion von Kontrastmitteln
DE69807647D1 (de) Vorrichtung zur verabreichung von zwei flüssigkeiten
DE59008901D1 (de) Vorrichtung zur Erstellung von medizinischen, insbesondere zahnmedizinischen, Prothetik- Passkörpern.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition